BRISTOL-MYERS SQUIBB COMPANY CORP - US 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2019-01-01 - 2022-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 10.210.993 0 1
2020 0 4.550.000 0 1
2019 0 23.499.991 0 2

Networking:

Partners:

Institution:Projects [No]:
NOVARTIS PHARMA4
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT3
ACADEMISCH ZIEKENHUIS GRONINGEN2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA2
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
KAROLINSKA INSTITUTE2
KATHOLIEKE UNIVERSITEIT LEUVEN2
PFIZER LIMITED2
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU2
SANOFIAVENTIS2
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA2
THE EUROPEAN MEDICINES AGENCY2
THE UNIVERSITY OF MANCHESTER2
UCB BIOPHARMA2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
ABBVIE INC1
ACADEMIC MEDICAL CENTRE AMSTERDAM1
AGENZIA REGIONALE DI SANITA1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASSOCIATION FRANCAISE GOUGEROTSJOGREN1
ASTRAZENECA1
ATTUROS LIMITED1
BAYER1
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM1
BIONOTUS1
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CONSIGLIO NAZIONALE DELLE RICERCHE1
COVANCE LABORATORIES1
ECOLOGIC INSTITUT GEMEINNUETZIGE1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
ECT OEKOTOXIKOLOGIE1
EIDGENOESSISCHE ANSTALT FUER WASSERVERSORGUNG ABWASSERREINIGUNG UND GEWAESSERSCHUTZ1
ELEVATE BV1
ELI LILLY AND COMPANY1
ELI LILLY AND COMPANY LIMITED1
ELLEGAARD GOTTINGEN MINIPIGS AS1
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE1
EUROPEAN ALLIANCE OF ASSOCIATIONS FOR RHEUMATOLOGY1
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE1
EUROPEAN INSTITUTE OF WOMEN'S HEALTH COMPANY LIMITED BY GUARANTEE1
F HOFFMANNLA ROCHE1
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA1
FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD1
GOETEBORGS UNIVERSITET1
HELSE STAVANGER HF1
HOPITAUX UNIVERSITAIRES DE STRASBOURG1
HOSPITAL CLINIC DE BARCELONA1
INNOVATION ACTA1
INSTITUT PASTEUR1
JANSSEN PHARMACEUTICA NV1
KING'S COLLEGE LONDON1
KUNGLIGA TEKNISKA HOEGSKOLAN1
LEUPHANA UNIVERSITAT LUNEBURG1
MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH1
MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
MERCK SHARP & DOHME CORP1
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS1
NEOTERYX LIMITED1
NOVO NORDISK1
ORCION BV1
OXFORD BIODYNAMICS PLC1
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON1
REGION HOVEDSTADEN1
REGION STOCKHOLM1
SIB SWISS INSTITUTE OF BIOINFORMATICS1
SIMOMICS LIMITED1
ST GEORGE'S HOSPITAL MEDICAL SCHOOL1
STICHTING ENTIS FOUNDATION1
STICHTING GROUP FOR RESEARCH AND ASSESSMENT OF PSORIASIS AND PSORIATIC ARTHRITIS EU1
STICHTING LAREB1
STICHTING RADBOUD UNIVERSITEIT1
SWANSEA UNIVERSITY1
TAKEDA DEVELOPMENT CENTRE EUROPE1
TAKEDA PHARMACEUTICALS INTERNATIONAL1
TEAM IT RESEARCH SL1
TERVEYDEN JA HYVINVOINNIN LAITOS1
TEVA PHARMACEUTICAL INDUSTRIES LIMITED1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST1
THE SYNERGIST1
THE UNIVERSITY OF EXETER1
TTOPSTART BV1
UNIVERSITA CATTOLICA DEL SACRO CUORE1
UNIVERSITA DEGLI STUDI DI FERRARA1
UNIVERSITA DEGLI STUDI DI UDINE1
UNIVERSITATSKLINIKUM ERLANGEN1
UNIVERSITE DE BRETAGNE OCCIDENTALE1
UNIVERSITE DE GENEVE1
UNIVERSITE DE PARIS1
UNIVERSITY COLLEGE DUBLIN1
UNIVERSITY OF BERGEN1
UNIVERSITY OF BIRMINGHAM1
UNIVERSITY OF BOLOGNA1
UNIVERSITY OF GLASGOW1
UNIVERSITY OF HELSINKI1
UNIVERSITY OF KWAZULUNATAL1

Constancy:

Total number of partners: 126
Partner loyalty:
Frequent Partner: (> 2 projects): 7
Rare Partner: 119
Frequent / Rare Partner Ratio: 0.06

Project overview: